Archive | Melanoma News

Melanoma Prevalence, Mortality Mostly Stable Over the Past 30 Years

Data from this new study suggest melanoma cases rose at a slower rate in lower-income countries, but the authors say that may be due to differences in case documentation.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Patients present with later stage melanoma during COVID-19 pandemic

Many melanoma patients presented with more advanced disease during the COVID-19 pandemic, according to a small study published in the Journal of the American Academy of Dermatology.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Sotigalimab Plus Nivolumab Shows Encouraging Activity in Anti–PD-1 Refractory Melanoma

The combination of sotigalimab (APX005M) and nivolumab (Opdivo) elicited durable responses with a reasonable safety profile in patients with melanoma who were refractory to anti–PD-1 therapy, according to data from a phase 2 trial (NCT03123783).

Read the full story

Posted in Melanoma News, Health Professionals, Clinical Trials

What’s Ahead for Melanoma Management

Immunotherapy, intralesional treatments, multidisciplinary care teams define rapidly-evolving multimodal approach.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest